The clock counts down to May for California’s audacious $3 billion experiment in funding stem cell research. That’s when Robert Klein, the architect of the program and acting president of the newly organized California Institute for Regenerative Medicine, hopes to begin cutting the first checks.
Office of Strategic Communication